| abstract |
A pharmaceutical or dietary preparation is provided which serves to reduce and / or block the adhesion of pathogenic substances and organisms to eukaryotic cells, particularly mammalian cells. This preparation contains at least one carbohydrate with a uronic acid unit at one of its ends. 10 to 100% of the existing terminal uronic acid units of the carbohydrates have a double bond, which lies in particular between the C 4 and C 5 atom. |